SESN2 Antibody, HRP conjugated

Shipped with Ice Packs
In Stock

Description

Composition and Mechanism

The HRP-conjugated SESN2 antibody typically combines a primary antibody specific to SESN2 with the HRP enzyme. This conjugation eliminates the need for secondary antibodies in detection workflows, streamlining assays. For example:

  • Target Specificity: The antibody binds to SESN2 epitopes, such as those in the EPR18907 clone (aa 1–250), with high affinity .

  • Enzymatic Activity: HRP catalyzes substrate reactions (e.g., luminol for chemiluminescence) to generate detectable signals proportional to SESN2 levels .

Western Blotting

Studies using SESN2 antibodies (non-HRP primary + HRP-secondary) demonstrate:

ParameterDetailsSource
Band SizePredicted: 54 kDa; Observed: 54 kDa in HeLa cell lysate
SensitivityDetects endogenous SESN2 even at low expression levels (e.g., HeLa)
ValidationKnockout controls (e.g., SESN2-KO HeLa lysate) confirm specificity

Immunoprecipitation (IP)

  • Efficiency: SESN2 antibodies effectively immunoprecipitate SESN2 from HeLa lysates, as shown by clean band isolation and minimal background in IP-Western blots .

  • Buffer Compatibility: Works in 5% NFDM/TBST blocking buffer with 1:1000 dilution .

Role in Autophagy and Drug Resistance

  • SESN2 upregulation in osteosarcoma cells reduces apoptosis and confers resistance to chemotherapeutic agents (cisplatin, doxorubicin) .

  • Mechanism: SESN2 knockdown increases cleaved PARP (apoptosis marker) and reduces LC3-II/LC3-I ratios (autophagy marker), sensitizing cells to drugs .

Regulation of Necroptosis in Liver Disease

  • SESN2 inhibits RIPK3-mediated necroptosis by blocking RIPK3 phosphorylation and necrosome formation .

  • Consequence: SESN2 deficiency exacerbates inflammation and oxidative stress in metabolic dysfunction-associated steatohepatitis (MASH) .

Technical Considerations

  • Dilution Range: 1:1000 for Western blotting, 1:30 for IP .

  • Cross-Reactivity: No observed cross-reactivity with SESN1 or SESN3 in validated models .

  • Storage: Stable in PBS with 0.02% sodium azide; avoid freeze-thaw cycles .

Research Limitations and Gaps

  • Most studies use non-conjugated SESN2 antibodies paired with HRP-secondary reagents . Direct HRP-conjugated SESN2 antibodies remain less documented, suggesting a niche for method optimization.

  • In vivo applications (e.g., animal models) require further validation of HRP-conjugated formats for tissue-specific detection .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship your orders within 1-3 business days of receipt. Delivery times may vary depending on the purchase method and location. Please contact your local distributors for specific delivery timelines.
Synonyms
DKFZp761M0212 antibody; DKFZp761M02121 antibody; Hi95 antibody; Hypoxia induced gene 95 antibody; MGC11758 antibody; OTTHUMP00000003641 antibody; OTTMUSP00000010184 antibody; RP23 63D8.3 antibody; SES2 antibody; SESN 2 antibody; SESN2 antibody; SESN2_HUMAN antibody; SEST2 antibody; Sestrin 2 antibody; Sestrin-2 antibody
Target Names
Uniprot No.

Target Background

Function
Sestrin 2 functions as an intracellular leucine sensor that negatively regulates the TORC1 signaling pathway through the GATOR complex. In the absence of leucine, it binds to the GATOR subcomplex GATOR2, inhibiting TORC1 signaling. Leucine binding to SESN2 disrupts this interaction, activating the TORC1 signaling pathway. This stress-inducible metabolic regulator also plays a role in protecting against oxidative and genotoxic stresses. It may negatively regulate protein translation in response to endoplasmic reticulum stress, via TORC1. Additionally, it may positively regulate transcription by NFE2L2 of genes involved in the response to oxidative stress by facilitating the SQSTM1-mediated autophagic degradation of KEAP1. It may also mediate TP53 inhibition of TORC1 signaling upon genotoxic stress. Furthermore, SESN2 may prevent the accumulation of reactive oxygen species (ROS) through its N-terminal domain's alkylhydroperoxide reductase activity. Although initially reported to contribute to oxidative stress resistance by reducing PRDX1, this has not been confirmed.
Gene References Into Functions
  1. High serum Sestrin 2 levels are associated with metabolic syndrome. PMID: 30099048
  2. Knockdown of sesn2 aggravates atherosclerotic processes by increasing pro-inflammatory reactions and ER stress in the endothelium via an AMPK-dependent mechanism, suggesting that sesn2 might be a novel therapeutic target for atherosclerosis. PMID: 28215577
  3. SESN2 is crucial for protecting cells against detrimental effects of mitochondrial damage, and RBX1 negatively regulates SESN2, hindering its stabilization. PMID: 29294217
  4. Sesn2 ablation increased UVA-induced Nrf2 induction and inhibits UVA-induced ROS production, indicating that Sesn2 acts as an upstream regulator of Nrf2. PMID: 27463837
  5. Tribbles pseudokinase 3 (TRB3) and sestrin 2 may contribute to the development of obesity and its complications and can be considered interesting therapeutic targets for the treatment of obesity. PMID: 28639842
  6. Overexpression of Sesn2 downregulated the expression of autophagy genes, upregulated pro-apoptotic gene expression, and downregulated specific extracellular matrix markers in stress-induced cells. PMID: 29518770
  7. These results suggest that sestrin 2 suppresses CRC cell growth through activation of the AMPK/mTORC1 pathway and induction of apoptosis, and could be a novel pharmacological target for the treatment of CRC. PMID: 28525387
  8. This study shows that differential Sestrin2-mediated regulation of mTORC1 and mTORC2 is necessary for the survival of glutamine-depleted lung cancer cells. PMID: 28723563
  9. There was significant overexpression of serum sesn2 protein and mRNA levels in the Alzheimer's Disease group compared to Mild Cognitive Impairment and the control group. PMID: 27567861
  10. Isorhapontigenin treatment induces autophagy and inhibits bladder cancer growth through MAPK8-JUN-dependent transcriptional induction of SESN2. PMID: 27171279
  11. Simple analysis of the reported "apo"-Sestrin2 structure reveals the clear presence of prominent, unmodeled electron density in the leucine-binding pocket that exactly accommodates the leucine observed in the higher resolution structure. PMID: 27649739
  12. Mass spectrometry analysis, western blot, and surface plasmon resonance (SPR) of affinity purified sesn1 and sesn2 proteins confirmed their identity; biophysical characteristics were observed using circular dichroism (CD) showing that sesn1 and sesn2 have a predominant α-helical structure. PMID: 28707664
  13. The results support a model in which leucine selectively promotes dephosphorylation of Sestrin2. PMID: 27010498
  14. The data are the first to indicate that SESN2 might be a novel prognostic marker for hepatocellular carcinoma. PMID: 28118855
  15. These results highlight Sestrin2 as a novel tumor suppressor, whose downregulation can accelerate both colitis and colon carcinogenesis. PMID: 26913956
  16. The up-regulation of SESN2 by mitochondrial dysfunction requires binding to ATF4. PMID: 26771712
  17. Sestrin2 silencing strongly inhibits cytokine-induced cell death. PMID: 26313705
  18. Sesn2 has two subdomains: the N-terminal domain reduces alkylhydroperoxide radicals through its helix-turn-helix oxidoreductase motif, and the C-terminal domain interacts with GATOR2, subsequently inhibiting mTORC1. PMID: 26612684
  19. Sestrin2 inhibits mTORC1 through modulation of GATOR complexes. PMID: 25819761
  20. Sestrin2: A Promising Therapeutic Target for Liver Diseases PMID: 26133704
  21. SESN2-AMPK signaling could exert a protective effect against glucose deprivation-induced cell death, and this effect is mediated by restoration of mitochondrial function. PMID: 25778901
  22. Sesn2 is a potential tumor suppressor in lung epithelial cells. The expression level of Sesn2 may serve as a prognostic marker for Chinese lung cancer patients in the clinic. PMID: 25962159
  23. These results indicate that Sestrin2 is a leucine sensor for the mTORC1 pathway. PMID: 26449471
  24. This study presents the 2.7 angstrom crystal structure of Sestrin2 in complex with leucine. PMID: 26586190
  25. Knockdown of Sestrin2 using small RNA interference promotes cell apoptosis and reactive oxygen species production induced by oxLDL. PMID: 25692450
  26. The findings suggest that a decreased expression of sestrin 2 is associated with an unfavorable prognosis, suggesting that it is a novel and crucial predictor for colorectal cancer metastasis. PMID: 25572852
  27. Sestrin2 has a hepatoprotective role against chronic ER stress. PMID: 24947615
  28. An AMPK-independent mechanism of mTORC1 inhibition by Sestrins mediated by their interaction with GATOR2 is reported. PMID: 25457612
  29. GAA promotes FoxO3 nuclear translocation and binding to the SESN2 enhancer. PMID: 25802279
  30. Data indicate that inactivation of Sestrin 2 (Sesn2) or nuclear factor erythroid 2-related factor 2 (Nrf2) induced reactive oxygen species-mediated proteasomal inhibition and platelet-derived growth factor receptor beta (Pdgfrbeta) accumulation. PMID: 25716320
  31. Sesn2 is oncogenic in skin squamous cell carcinoma and melanoma. PMID: 25378405
  32. Knockdown of SESN2 using small RNA interference promotes cellular toxicity of angiotensin II, as well as a reduction in cell viability, exacerbation of oxidative stress, and stimulation of apoptosis. PMID: 24838122
  33. Data indicate that sestrin2 expression is upregulated by dopamine D2 receptor. PMID: 25024286
  34. Sestrin2 inhibits uncoupling protein 1 expression through suppressing reactive oxygen species. PMID: 24825887
  35. Results show that ATF4-regulated SESN2 expression presents a new link between ER stress and mTOR inhibition and autophagy. PMID: 23916134
  36. Results imply that SESN2 could serve as both a biomarker and a drug target in the clinical management of COPD. PMID: 24046361
  37. Sesn2 acts as a new energetic stress sensor, which appears to be protective against energetic stress-induced apoptosis that integrates the pro-survival function of Akt and the negative regulation of mTOR. PMID: 23238567
  38. The JNK pathway mediated sestrin 2 expression and contributed to autophagy induction, highlighting the relationship of sestrin 2 and autophagy and the JNK signaling pathway. PMID: 22982090
  39. Sestrin-2 redistributes to neuronal soma in human immunodeficiency virus (HIV)-associated neurocognitive disorders. PMID: 22450766
  40. Sesn2 is required for the Nrf2-mediated cytoprotective activity against hydrogen peroxide. PMID: 22749810
  41. In breast cancer cells, SESN2 is associated with AMPK. PMID: 22363791
  42. Signaling by the AMP-activated protein kinase was also involved as a downstream target of sestrin2. PMID: 21418191
  43. PDGFRbeta accumulation is associated with increased oxidative stress and cellular damage in SESN2 silenced human glioblastoma U87 cells. PMID: 21536039
  44. Results show that, unlike Srx, Sesn 2 is not a sulfinic Prx reductase. PMID: 19113821
  45. Results show that sestrins, a family of proteins whose expression is modulated by p53, are required for regeneration of peroxiredoxins containing Cys-SO(2)H. PMID: 15105503
  46. Depletion of Sestrin2 or Dram failed to affect autophagy in p53-deficient cells. PMID: 19377293

Show More

Hide All

Database Links

HGNC: 20746

OMIM: 607767

KEGG: hsa:83667

STRING: 9606.ENSP00000253063

UniGene: Hs.469543

Protein Families
Sestrin family
Subcellular Location
Cytoplasm.
Tissue Specificity
Widely expressed.

Q&A

What is SESN2 and why is it an important research target?

SESN2 (Sestrin2) is a stress-inducible metabolic regulator that responds to diverse cellular stresses. It plays critical roles in:

  • Inhibiting mTORC1 signaling through the GATOR complex as an intracellular leucine sensor

  • Protecting against oxidative and genotoxic stresses

  • Mediating mitophagy and mitochondrial health

  • Regulating cellular metabolism through AMPK pathways

  • Dampening aerobic glycolysis in glucose-limiting conditions

SESN2 is widely expressed across multiple tissues and primarily localized in the cytoplasm, with a canonical protein length of 480 amino acid residues and a mass of approximately 54.5 kDa . Its involvement in multiple stress response pathways makes it a valuable target for researchers studying cellular stress, metabolism, and disease states.

What are the expected molecular weights when detecting SESN2 with antibodies?

When using SESN2 antibodies in Western blot applications, researchers should expect:

  • The canonical molecular weight of 54-60 kDa for the full-length protein

  • Potential variations in observed weights (54-60 kDa range) depending on post-translational modifications

  • In some cellular stress conditions, alternative bands may be observed

This information is critical for proper identification of SESN2 in experimental samples. Always include positive controls such as HEK-293, HeLa, or K-562 cell lysates, which have been confirmed to express detectable levels of SESN2 .

What are the optimal conditions for using HRP-conjugated SESN2 antibodies in Western blotting?

For optimal Western blot results with HRP-conjugated SESN2 antibodies:

ParameterRecommended Conditions
Sample loading20-50 μg total protein per lane
Blocking solution5% non-fat dry milk in TBST (preferred over BSA)
Primary antibody dilution1:2000-1:12000 (optimize for each specific antibody)
Incubation timeOvernight at 4°C for primary; 40-60 min at room temperature for secondary
Washing3-5 washes with TBST, 5-10 minutes each
VisualizationStandard ECL detection systems

When studying SESN2 interactions with binding partners like IGF2BP3 or HK2 mRNA, extended exposure times may be necessary to detect complex formation . For stress-induced upregulation experiments, ensure adequate sample collection time points as SESN2 expression increases substantially after 12 hours of LPS stimulation .

How should researchers validate SESN2 antibody specificity in their experimental systems?

Rigorous validation of SESN2 antibodies is essential to ensure experimental reliability:

  • Genetic controls: Use SESN2 knockout (Sesn2^-/-) samples as negative controls

  • Overexpression controls: Include SESN2-overexpressing samples (e.g., cells transfected with plasmid carrying the SESN2 gene)

  • Peptide competition assay: Pre-incubate antibody with immunizing peptide to confirm specific binding

  • Cross-reactivity testing: Test across multiple species if working with non-human models

  • Multiple antibody validation: Compare results from antibodies targeting different epitopes of SESN2

Validation data should be documented and included in publications. For example, research has shown that SESN2 antibodies can reliably detect the induced expression in hepatocellular carcinoma (HCC) cells under glucose deprivation conditions and in macrophages after extended LPS stimulation .

How can HRP-conjugated SESN2 antibodies be utilized to study SESN2's role in stress granule formation?

SESN2 has been implicated in stress granule dynamics, particularly in relation to stabilizing hexokinase 2 (HK2) mRNA. To study this role:

  • Co-localization studies:

    • Use HRP-conjugated SESN2 antibodies alongside fluorescently-labeled stress granule markers (e.g., G3BP1)

    • Perform proximity ligation assays to visualize spatial relationships between SESN2 and stress granule components

  • RNA-protein interaction analysis:

    • Combine RNA pull-down assays with SESN2 antibody detection to identify SESN2-RNA complexes

    • According to research, SESN2 competes with IGF2BP3 for binding to the 3'-UTR region of HK2 mRNA, affecting its stability

  • Stress-induced dynamics:

    • Track SESN2 translocation to stress granules under various stressors (oxidative, ER stress, nutrient deprivation)

    • Time-course experiments have shown SESN2 association with mitochondria after 12h of LPS priming followed by ATP treatment

These approaches can reveal how SESN2 contributes to stress granule formation and the fate of specific mRNAs during cellular stress responses.

What are the best practices for using SESN2 antibodies in ChIP experiments to study epigenetic regulation?

When using SESN2 antibodies for chromatin immunoprecipitation (ChIP) studies:

  • Crosslinking optimization:

    • For SESN2-associated chromatin studies, use 1% formaldehyde for 10 minutes at room temperature

    • Double crosslinking with disuccinimidyl glutarate (DSG) followed by formaldehyde can improve detection of indirect DNA associations

  • Sonication parameters:

    • Optimize to achieve 200-500 bp DNA fragments

    • Verify fragment size by agarose gel electrophoresis

  • Antibody selection:

    • For studying SESN2 regulation, combine SESN2 antibodies with antibodies against histone marks like H3K9me3 and H3K9ac

    • Research has shown SETDB1 regulates SESN2 expression by promoting H3K9me3 modifications at the SESN2 promoter

  • Controls:

    • Include IgG control, input control, and positive control regions (known SESN2-regulated genes)

    • Use GAPDH as a negative control region, as studies show no significant accumulation of histone modifications in this region

  • Data analysis:

    • Normalize to input and IgG controls

    • Compare enrichment across different experimental conditions

This approach has revealed that SETDB1 accumulates on the SESN2 promoter and promotes recruitment of H3K9me3, leading to transcriptional repression .

How should researchers interpret multiple SESN2 bands or inconsistent molecular weights in Western blots?

When encountering multiple bands or unexpected molecular weights:

  • Post-translational modifications: SESN2 can undergo phosphorylation and ubiquitination , potentially altering migration patterns

  • Isoform detection: Verify which isoforms your antibody recognizes and whether tissue-specific variants exist

  • Degradation products: Fresh sample preparation and inclusion of protease inhibitors can minimize degradation

  • Cross-reactivity: Test specificity using:

    • siRNA/shRNA knockdown: Knockdown experiments using shSESN2 (sequence: 5′-GGTCCACGTGAACTTGCTGC-3′) have successfully validated SESN2 bands

    • Knockout controls: Compare with Sesn2^-/- samples when available

  • Stress-induced modifications: Under certain stress conditions, SESN2 can form complexes that alter its migration pattern

    • Research shows stress can induce SESN2-SQSTM1 interactions in both cytoplasmic and mitochondrial compartments

To distinguish between specific and non-specific bands, researchers should compare results across multiple antibodies and validate with genetic approaches.

How can SESN2 antibodies be utilized to study its role in mitophagy and mitochondrial quality control?

For investigating SESN2's role in mitophagy:

  • Mitochondrial fractionation studies:

    • Use HRP-conjugated SESN2 antibodies to detect SESN2 recruitment to mitochondria

    • Research shows SESN2 associates with mitochondria after stress exposure

    • Include mitochondrial markers (e.g., TOM20) to confirm fractionation quality

  • Co-immunoprecipitation approaches:

    • Immunoprecipitate with SESN2 antibodies to identify mitophagy-related binding partners

    • Studies have revealed SESN2 interactions with SQSTM1 in both cytoplasm and mitochondrial fractions after stimulation

  • Functional assays:

    • Compare mitochondrial clustering and perinuclear aggregation between wild-type and Sesn2^-/- cells

    • Research indicates SESN2 facilitates mitochondrial priming by mediating SQSTM1 aggregation and binding to ubiquitinated mitochondria

  • Mitophagy flux assessment:

    • Use SESN2 antibodies alongside mitophagy markers (LC3, PINK1, Parkin)

    • Sesn2^-/- mice display defective mitophagy upon immune stimulation

These approaches can help elucidate how SESN2 contributes to mitochondrial quality control, particularly in contexts like inflammation where SESN2-mediated mitophagy protects against NLRP3 inflammasome hyperactivation .

What are the optimal approaches for studying SESN2's role in IgE class switching in B cells?

When investigating SESN2's role in B cell immunology:

  • Detection of SESN2 in B cells:

    • RT-PCR has confirmed Sesn2 mRNA expression in mouse B cell lines (L10A6.2 and A20.3) and purified splenic B cells

    • LPS stimulation enhances SESN2 expression in B cells

  • Analyzing class switch recombination:

    • Use germline transcript (GLT) analysis:

      • IL-4-induced GLTε expression is reduced in Sesn2^-/- splenocytes

      • IL-4-induced GLTγ1 is also reduced in Sesn2^-/- cells

      • Other cytokine-induced GLTs (GLTγ3, GLTγ2b, GLTα, GLTγ2c) are not affected by SESN2 deficiency

  • Promoter activity assays:

    • Luciferase reporter assays have shown that SESN2 overexpression enhances IL-4-induced GLTε promoter activity

    • SESN2 affects IgE CSR by enhancing IL-4-induced GLTε transcription

  • AMPK pathway investigation:

    • AMPK activation (phosphorylated AMPK; p-AMPK) is reduced in Sesn2^-/- B cells

    • AICAR (an AMPK activator) rescues reduced IL-4-induced sIgE expression in Sesn2^-/- B cells

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.